Shishiba Y, Yanagishita M, Hascall V C, Takeuchi Y, Yokoi N
Bone Research Branch, National Institute of Dental Research, Bethesda, Maryland 20892.
J Biol Chem. 1988 Feb 5;263(4):1745-54.
A Fisher rat thyroid cell line was maintained in culture and the cells were labeled with [3H]glucosamine, [35S]sulfate, and [35S]cysteine to examine the synthesis of proteoglycans. 3H and 35S radioactivity from these precursors were incorporated into both chondroitin sulfate (CS) and heparan sulfate (HS) proteoglycans. CS proteoglycans were almost exclusively secreted into the medium while HS proteoglycans remained mainly associated with the cell layer. Single chain glycosaminoglycans released by papain digestion or alkaline borohydride treatment of either the CS or HS proteoglycans had average molecular weights of approximately 30,000 on Sepharose CL-6B chromatography. Both CS and HS proteoglycans were relatively small and contained only one or two glycosaminoglycans chains. 3H and 35S incorporation into both CS and HS proteoglycans were increased by thyroid-stimulating hormone (TSH) in a dose-dependent manner, which is in part explained by an adenylate cyclase-dependent mechanism as indicated by a similar effect in response to dibutyryl cAMP. TSH enhanced the incorporation of 35S into CS from [35S]cysteine about 1.5-fold and that from [35S]sulfate about 2-fold. This result demonstrated that the increased 35S incorporation from the [35S]sulfate precursor reflects an actual increase in sulfate incorporation and is not simply a result from an apparent increase in specific activity of the phosphoadenosine phosphosulfate donor. Analysis of disaccharides from chondroitinase digests revealed that the proportion of non-sulfated, 4-sulfated, and 6-sulfated disaccharides was not altered appreciably by TSH. These results, together with the disproportionate increase in 3H incorporation into CS from [3H]glucosamine, indicated that TSH increased the specific activity of the 3H label as well. Chase experiments revealed that CS proteoglycans were rapidly (t1/2 = 15 min) secreted into the medium and that the degradation of cell-associated proteoglycans was enhanced by TSH.
将 Fisher 大鼠甲状腺细胞系进行培养,并用[3H]氨基葡萄糖、[35S]硫酸盐和[35S]半胱氨酸对细胞进行标记,以检测蛋白聚糖的合成。这些前体物质中的 3H 和 35S 放射性被整合到硫酸软骨素(CS)和硫酸乙酰肝素(HS)蛋白聚糖中。CS 蛋白聚糖几乎完全分泌到培养基中,而 HS 蛋白聚糖主要仍与细胞层相关。通过木瓜蛋白酶消化或碱性硼氢化钠处理 CS 或 HS 蛋白聚糖释放的单链糖胺聚糖,在 Sepharose CL - 6B 色谱上的平均分子量约为 30,000。CS 和 HS 蛋白聚糖相对较小,仅含有一两条糖胺聚糖链。促甲状腺激素(TSH)以剂量依赖性方式增加了 3H 和 35S 整合到 CS 和 HS 蛋白聚糖中的量,这部分是由腺苷酸环化酶依赖性机制解释的,如对二丁酰 cAMP 的类似反应所示。TSH 使 35S 从[35S]半胱氨酸整合到 CS 中的量增加约 1.5 倍,从[35S]硫酸盐整合到 CS 中的量增加约 2 倍。该结果表明,从[35S]硫酸盐前体增加的 35S 整合反映了硫酸盐整合的实际增加,而不仅仅是磷酸腺苷磷酸硫酸供体比活性明显增加的结果。对来自软骨素酶消化产物的二糖分析表明,TSH 对非硫酸化、4 - 硫酸化和 6 - 硫酸化二糖的比例没有明显改变。这些结果,连同从[3H]氨基葡萄糖到 CS 的 3H 整合的不成比例增加,表明 TSH 也增加了 3H 标记的比活性。追踪实验表明,CS 蛋白聚糖迅速(t1/2 = 15 分钟)分泌到培养基中,并且 TSH 增强了细胞相关蛋白聚糖的降解。